Literature DB >> 10647695

Selective cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better alternative for renal colic?

S Y Nakada1, T J Jerde, D E Bjorling, R Saban.   

Abstract

PURPOSE: To quantitate the effects of a selective cyclooxygenase (COX)-2 inhibitor, NS-398, on porcine and human ureteral contractility in vitro.
MATERIALS AND METHODS: This study was performed in 3 distinct groups. In group 1, segments of ureter were obtained from freshly sacrificed domestic swine. Sections were isolated and suspended longitudinally. Twenty-four ureteral segments were treated with either indomethacin (a nonselective COX inhibitor), NS-398 (selective COX-2 inhibitor), or DMSO (control). Spontaneous contractions were then recorded in each group. In group 2, fifteen segments of human ureter were obtained from patients undergoing donor nephrectomy or ureteral reimplantation. Segments were isolated and suspended as above, and treated with either indomethacin, NS-398, or DMSO. In group 3, eighteen sections of human ureter obtained from donor nephrectomy patients were passively sensitized for 20 hours in ragweed allergic donor serum. Ureteral segments were then treated with either indomethacin, NS-398 or DMSO, and then the segments were subsequently exposed to ragweed antigen and contractions were subsequently recorded.
RESULTS: In group 1, the average time to 100% inhibition of spontaneous contraction was 48.8 minutes (S.E.M. = 7.9) for indomethacin, 65.7 minutes (S.E.M. 6.7) for NS-398, and beyond 150 minutes for DMSO. The percent reduction was 100% for indomethacin (S.E.M. = 0), 92.5% for NS-398 (S.E.M. 4.9%), and 52.9% for DMSO (s.e.m. = 10.8%). In group 2, the average time to 100% inhibition was 29 minutes (S.E.M. = 10.4) for indomethacin, 21 minutes (S.E.M. 4.8) for NS-398, and beyond 150 minutes for DMSO. The percent reduction was 100% for indomethacin (S.E.M. = 0), 100% (S.E.M. = 0) for NS-398, and 20% (S.E.M. = 12%) for DMSO. In group 3, ragweed sensitized ureters treated with DMSO (control group) contracted an average maximum of 10 times per 5 minutes. Antigen failed to induce contractions of sensitized tissues treated with indomethacin or NS-398.
CONCLUSION: A selective COX-2 inhibitor (NS-398) reduces ureteral contractility as effectively as indomethacin (a nonselective COX inhibitor) in both porcine and human ureteral segments in vitro (p <0.05). Selective COX-2 inhibitors may have significant clinical potential in treating renal colic as they cause less gastric ulceration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10647695

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Adjunctive therapy to promote stone passage.

Authors:  Geoffrey R Nuss; Judson D Rackley; Dean G Assimos
Journal:  Rev Urol       Date:  2005

2.  Analgesic Effects and Safety of Desmopressin, Tramadol and Indomethacin in Patients with Acute Renal Colic; A Randomized Clinical Trial.

Authors:  Mehdi Shirazi; Mehdi Salehipour; Mohammad Amin Afrasiabi; Alireza Aminsharifi
Journal:  Bull Emerg Trauma       Date:  2015-04

3.  Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones.

Authors:  Jian Lin Lv; Qing Lai Tang
Journal:  Urolithiasis       Date:  2014-08-20       Impact factor: 3.436

4.  Effects of a non-selective COX inhibitor and selective COX-2 inhibitors on contractility of human and porcine ureters in vitro and in vivo.

Authors:  V Chaignat; H Danuser; M H Stoffel; S Z'brun; U E Studer; M Mevissen
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

5.  A single oral dose of Silodosin and Diclofenac sodium is effective in reducing pain after ureteric stent removal: a prospective, randomized, double blind placebo-controlled study.

Authors:  Goto Gangkak; Ram Dayal Teli; Sher Singh Yadav; Vinay Tomar; Shivam Priyadarshi; Satinder Pal Aggarwal
Journal:  Springerplus       Date:  2016-01-07

6.  Ureteral Access Sheath Influence on the Ureteral Wall Evaluated by Cyclooxygenase-2 and Tumor Necrosis Factor-α in a Porcine Model.

Authors:  Søren Kissow Lildal; Rikke Nørregaard; Kim Hovgaard Andreassen; Frederikke Eichner Christiansen; Helene Jung; Malene Roland Pedersen; Palle Jörn Sloth Osther
Journal:  J Endourol       Date:  2017-01-24       Impact factor: 2.942

7.  Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study.

Authors:  Kim Davenport; Anthony G Timoney; Francis X Keeley
Journal:  Urol Res       Date:  2007-05-26

Review 8.  The Role of Non-Steroidal Anti-Inflammatory Drugs in Renal Colic.

Authors:  Kim Davenport; Elizabeth Waine
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.